2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, enc...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) Jg. 143; H. 5; S. e35
Hauptverfasser: Otto, Catherine M, Nishimura, Rick A, Bonow, Robert O, Carabello, Blase A, Erwin, 3rd, John P, Gentile, Federico, Jneid, Hani, Krieger, Eric V, Mack, Michael, McLeod, Christopher, O'Gara, Patrick T, Rigolin, Vera H, Sundt, 3rd, Thoralf M, Thompson, Annemarie, Toly, Christopher
Format: Journal Article
Sprache:Englisch
Veröffentlicht: United States 02.02.2021
Schlagworte:
American Heart Association
Cardiology - organization & administration
Heart Valve Diseases - therapy
Humans
United States
United States
mitral regurgitation
pulmonic stenosis
AHA Scientific Statements
anscatheter aortic valve replacement or implantation
prosthetic valve
anticoagulation therapy
tricuspid regurgitation
aortic regurgitation
aortic stenosis
infective endocarditis
bicuspid aortic valve
mitral stenosis
pulmonic regurgitation
mitral transcatheter edge-to-edge repair
cardiac surgery
valvular heart disease
tricuspid stenosis
ISSN:1524-4539, 1524-4539
Online-Zugang:Weitere Angaben
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This executive summary of the valvular heart disease guideline provides recommendations for clinicians to diagnose and manage valvular heart disease as well as supporting documentation to encourage their use. A comprehensive literature search was conducted from January 1, 2010, to March 1, 2020, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, Cochrane, Agency for Healthcare Research and Quality Reports, and other selected database relevant to this guideline. Structure: Many recommendations from the earlier valvular heart disease guidelines have been updated with new evidence and provides newer options for diagnosis and treatment of valvular heart disease. This summary includes only the recommendations from the full guideline which focus on diagnostic work-up, the timing and choice of surgical and catheter interventions, and recommendations for medical therapy. The reader is referred to the full guideline for graphical flow charts, text, and tables with additional details about the rationale for and implementation of each recommendation, and the evidence tables detailing the data considered in developing these guidelines.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
content type line 23
ISSN:1524-4539
1524-4539
DOI:10.1161/CIR.0000000000000932